Aortic stenosis medical therapy

Revision as of 14:46, 12 November 2011 by Mohammed Sbeih (talk | contribs)
Jump to navigation Jump to search

Aortic Stenosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Aortic Stenosis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Cardiac Stress Test

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography

Cardiac Catheterization

Aortic Valve Area

Aortic Valve Area Calculation

Treatment

General Approach

Medical Therapy

Surgery

Percutaneous Aortic Balloon Valvotomy (PABV) or Aortic Valvuloplasty

Transcatheter Aortic Valve Replacement (TAVR)

TAVR vs SAVR
Critical Pathway
Patient Selection
Imaging
Evaluation
Valve Types
TAVR Procedure
Post TAVR management
AHA/ACC Guideline Recommendations

Follow Up

Prevention

Precautions and Prophylaxis

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Aortic stenosis medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Aortic stenosis medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Aortic stenosis medical therapy

CDC on Aortic stenosis medical therapy

Aortic stenosis medical therapy in the news

Blogs on Aortic stenosis medical therapy

Directions to Hospitals Treating Aortic stenosis medical therapy

Risk calculators and risk factors for Aortic stenosis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Claudia P. Hochberg, M.D. [2]; Abdul-Rahman Arabi, M.D. [3]; Keri Shafer, M.D. [4]; Priyamvada Singh, MBBS [5]; Assistant Editor-In-Chief: Kristin Feeney, B.S. [6]

Overview

Prior to surgical intervention, clinicians may utilize medical therapy for aortic stenosis treatment. Although aortic valve replacement is the mainstay of treatment of symptomatic aortic stenosis (AS), as it improves both the symptoms and life expectancy in aortic stenosis patients, in contrast to medical therapy alone which may improve the symptoms without prolonging life expectancy. When pharmacological therapies are used; Caution must be taken in avoiding complications such as excess vasodilation, as it could lead to functional decline in the patient. Medical treatment is primarily symptomatic.

Medical Therapy

Pharmacotherapy

Aortic stenosis may be medically treated to control symptoms. Extreme care should be taken to avoid excess vasodilation in the patient with critical aortic stenosis which could precipitate a downward spiral of low forward output, impaired subendocardial perfusion, ischemia and further reduction in forward output. Medications that may be used to control the symptoms of aortic stenosis includes:

  • Beta blockers and angiotensin-converting enzyme inhibitors, they are generally safe for asymptomatic patients with preserved left ventricular systolic function.
  • Nitroglycerin is helpful in relieving angina pectoris symptoms but should be used cautiously to avoid hypotention.
  • Some studies showed that patients with calcific AS who receive HMG-CoA reductase inhibitors (statins) exhibit slower progression of leaflet calcification and aortic valve area reduction than those who do not.

Patients with severe AS (< 1.0 cm2) should avoid strenuous physical activity. If the patient has symptoms of heart failure, the symptoms should be controlled and he should have sodium restriction. The physician may administer diuretics and digoxin cautiously to avoid dehydration, hypovolemia and significant reduction in cardiac output.

References

Template:WH Template:WS